Related Experiment Videos
Association Between Anemia, Bleeding, and Transfusion with Long-term Mortality Following Noncardiac Surgery.
Nathaniel R Smilowitz1, Brandon S Oberweis2, Swetha Nukala3
1Division of Cardiology, Department of Medicine, New York University School of Medicine, New York.
The American Journal of Medicine
|November 3, 2015
Summary
Preoperative anemia, bleeding, and red blood cell transfusions increase long-term mortality risk after noncardiac surgery. Minimizing anemia and bleeding, alongside restrictive transfusion strategies, may improve patient outcomes.
Area of Science:
- Perioperative Medicine
- Transfusion Medicine
- Surgical Outcomes Research
Background:
- Preoperative anemia is a known risk factor for short-term mortality in noncardiac surgery.
- Optimal transfusion thresholds for patients undergoing surgery remain unclear.
- Long-term consequences of anemia, hemorrhage, and transfusions require further investigation.
Purpose of the Study:
- To determine the long-term outcomes associated with preoperative anemia, perioperative hemorrhage, and red blood cell (RBC) transfusion.
- To analyze the impact of these factors on long-term mortality after noncardiac surgery.
Main Methods:
- A long-term follow-up study of 3050 patients undergoing hip, knee, or spine surgery.
- Preoperative anemia defined as hemoglobin < 13 g/dL (men) or < 12 g/dL (women).
- Hemorrhage identified via ICD-9 codes; survival data from Social Security Death Index; logistic regression used for analysis.
Main Results:
- 17.6% of patients had preoperative anemia, 1% experienced hemorrhage, and 25% received RBC transfusions.
- Anemia (HR 3.91) and hemorrhage (HR 5.28) were independently linked to long-term mortality.
- RBC transfusion was associated with mortality (HR 3.96), with the risk attenuated by anemia severity.
Conclusions:
- Preoperative anemia, perioperative bleeding, and RBC transfusion are associated with increased long-term mortality post-noncardiac surgery.
- Strategies to reduce anemia and bleeding are recommended.
- Restrictive transfusion strategies and further research into adverse event mechanisms are warranted.
Related Concept Videos
Venous Thrombosis IV: Nursing Management
153
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
153
Blood Transfusion
2.0K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.0K
Blood Transfusion and Agglutination
13.9K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
13.9K
Bone Marrow Sampling and Transplants
734
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
734
Disorders of Hemostasis
1.8K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.8K
Tissue Transplantation
804
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
804